By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050



Company News
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? 5/19/2015 10:00:29 AM
Teva (TEVA)To Present New Respiratory Data At 2015 Annual International Meeting Of The American Thoracic Society 5/15/2015 11:30:58 AM
Teva (TEVA) Presents Further Data From Phase IIb With TEV-48125 In Chronic Migraine At The International Headache Society Congress (IHC): Efficacy And Safety Results At All Doses And Endpoints Present Robust Case For Progression To Phase III 5/14/2015 11:09:12 AM
Mylan (MYL) Chairman Tells Investors He Would Consider Buying Rival Teva (TEVA) 5/11/2015 7:15:00 AM
Teva (TEVA) Completes Acquisition Of Auspex Pharmaceuticals (ASPX) 5/5/2015 8:47:30 AM
Teva (TEVA) Reports First Quarter 2015 Results 4/30/2015 1:27:26 PM
Teva (TEVA) Sends Letter To Mylan (MYL) Board 4/30/2015 1:21:25 PM
Teva (TEVA) Launches Generic Abilify Tablets In The United States 4/29/2015 9:59:02 AM
Teva (TEVA) Continues To Invigorate Injectable Portfolio With The Launch Of Argatroban Injection In The United States 4/28/2015 8:51:24 AM
Teva (TEVA) Reiterates Commitment To Cash-And-Stock Acquisition Of Mylan (MYL) For $82.00 Per Share 4/27/2015 8:44:35 AM